Contact Us
Drug Search Results
More Filters [+]

Canosimibe

Alternative Names: canosimibe, ave-5530, ave 5530, ave5530
Latest Update: 2020-09-22
Latest Update Note: News Article

Product Description

Canosimibe is a derivative of the cholesterol absorption inhibitor ezetimibedesigned to be non-soluble and target the luminal surface of the GI tract. (Sourced from: https://pubchem.ncbi.nlm.nih.gov/compound/Canosimibe)

Mechanisms of Action: ACAT Inhibitor

Novel Mechanism: Yes

Modality: Small Molecule

Route of Administration: Oral

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: None

Approved Indications: None

Known Adverse Events: None

Company: Sanofi
Company Location: PARIS I0 75008
Company CEO: Paul Hudson
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Canosimibe

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 3: Hypercholesterolemia

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success
2006-7041-83/hah

N/A

Not yet recruiting

Depressive Disorder

2018-10-15

2008-002849-23

P3

Completed

Hypercholesterolemia

2010-06-04

2008-001550-41

P3

Completed

Hypercholesterolemia

2009-06-17

EFC6910

P3

Terminated

Hypercholesterolemia

2009-06-01

Recent News Events

Date

Type

Title

09/22/2020

News Article

 Avocor Announces Three New 55" Displays Ideal for Collaborating at Work, Schools or Home

Did PRYZM just deliver the data you were looking for?
Did you try our Excel download too?

Now that you’ve used PRYZM, we hope you’re able to see for yourself that it was designed and developed by people who actually use this data for a living. By applying next-generation technology for aggregating and curating this info across multiple key sources PRYZM delivering the latest information at your fingertips just the way you need it and with industry leading speed and cost effectiveness.

Our subscribers enjoy unlimited searches and receive this data on their own secure instance so they can overlay any additional internal/proprietary data on top of the search results and blend that data with real-time industry intel from PRYZM. Discover how you can continue to uncover the competitive landscape and drive strategy.

Suggestions